-
E-mail
sievers.china@veolia.com
- Phone
-
Address
Building 5-6, Chuangqi Tiandi, 1761 Zhangdong Road, Pudong
Veolia Sievers analyzer
Revolutionary progress in bacterial endotoxin detection - microfluidic technology and recombinant reagents leading the trend
Date: 2025-09-08Read: 0
Through modern microfluidic endotoxin detection
Enhance efficiency and regulatory confidence
The microfluidic bacterial endotoxin detection system represents an important breakthrough in analytical efficiency and technology. The application of microfluidic technology in endotoxin detection aims to simplify the critical safety and quality assessment process in drugs and aqueous matrices. Although many institutions are considering using complex robotic technology to automate bacterial endotoxin testing and sampling processes,But microfluidic technology provides a simpler solution -Accurate results can be obtained without relying on bulky robot systems, while significantly reducing manual operation time.
Recombinant Cascade Reagents (rCR) are non animal derived reagents that can replace the more commonly used natural horseshoe crab reagents. Using rCR on microfluidic platforms can further shorten detection time due to its faster reaction speed. In most parts of the world,RCR or rFC (recombinant factor C) reagents are considered as alternative methods to horseshoe crab reagents as specified in the pharmacopoeia.
To transition to microfluidic systems and use these recombinant reagents, alternative methods must be validated or confirmed through testing. For this purpose, users should refer to the initial validation package provided by the reagent manufacturer to ensure that it meets the factory's requirements. However, in some cases, users may choose to conduct additional testing. This can be done through natural occurring endotoxins (NOEs) or bacterial endotoxin reference standards (RSE). Ideally, a gap analysis should be conducted to determine whether further testing is needed. Intermediate product samples, raw materials, ultrapure water, etc. can be selected for further testing to ensure the compatibility of the recombinant reagent.
benefitUsing microfluidic technology
Validation of the recombinant cascade reagent rCR for accelerated recombination
One of the attractive advantages of modern microfluidic systems is the ability to significantly reduce the time required for rCR validationTraditional methods are often time-consuming and labor-intensive, and can easily create bottlenecks in research and development, quality control, and production processes. By automating and optimizing key steps, these advanced systems can accelerate the entire validation workflow, achieve rapid delivery of critical analytical data, and enable pharmaceutical companies to bring new products to market more quickly and efficiently.
High throughput
Laboratory efficiency improvement and cost savings
Advanced microfluidic platforms, such asSievers®Eclipse bacterial endotoxin detectorAdopting innovative technology to achieve simultaneous detection of multiple samples. By automatically adding reagents to the sample in a 1:1 ratio,And use pre embedded standard curves and specialized microplates for positive product control (PPC)Significantly reduces the risk of human error during the dilution process of standard samples. No need to manually label each PPC duplicate sample.Analysts can complete multi sample testing and complete 5-point standard curves in a very short period of time.
Sievers®Eclipse bacterial endotoxin detector,
Meets the requirements of pharmacopoeias of various countries,
Using microfluidic technology, only 27 pipetting steps are required,
Reduce the usage of horseshoe crab reagent by up to 90%,
And recombinant cascade reagent rCR can be used
In addition to the speed advantage, the efficiency improvement brought by modern microfluidic systems has a significant contribution to the overall laboratory productivity.By reducing manual operations and lowering the risk of human errorLaboratories can reallocate valuable human resources to more complex or critical tasks. The reduction in verification time also releases instrument usage time, potentially increasing sample processing capacity without the need for additional equipment investment. In addition,Simplified processes can reduce the consumption of reagents and consumables over time, ultimately bringing tangible cost savings to organizations.
Precision and reliabilitySuitable for multiple samples
A powerful microfluidic platform will ensure high precision and reliability across multiple sample typesWhether it is complex drug formulations, active pharmaceutical ingredients (APIs), or various water samples - from ultrapure water used in drug production to environmental water sources - these advanced platforms can continuously provide accurate and reproducible endotoxin testing results. Its versatility makes it an essential tool for various applications throughout the pharmaceutical lifecycle, covering the entire process from early development to final product release testing.
Ensure regulatory compliancePatient safety
In the highly regulated pharmaceutical industry, reliable and efficient validation of tests such as bacterial endotoxin testing is crucial.Advanced microfluidic systems can support data reliability and traceabilityThese key features are crucial for meeting the strict requirements of regulatory agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). By ensuring that bacterial endotoxin testing can be quickly and accurately validated, these systems directly improve the overall quality and safety of drugs, ultimately safeguarding patient health. Using microfluidic technology combined with recombinant reagents,It can ensure patient safety and improve efficiency, and is more effective compared to other endotoxin testing methodsIn the field of water quality testing, microfluidic technology can provide key guarantees to ensure that water sources meet established safety standards.
Conclusion
In summary, modern microfluidic endotoxin detection techniques, such asSievers®Eclipse bacterial endotoxin detectorNot just an analytical tool, but also a comprehensive solution,Empowering laboratories to achieve unprecedented efficiency, accuracy, and regulatory compliance in endotoxin detection processesIts impact runs through multiple aspects of laboratory operations, from process optimization and product development acceleration to patient safety improvement. Its accuracy and reliability in diverse samples, combined with improved throughput and cost savings, make it a powerful tool for modern pharmaceutical testing. As the industry continues to prioritize operations and patient safety, this innovative approach is becoming an accelerator for driving more efficient, compliant, and sustainable quality control processes. For laboratories seeking to switch to animal free reagents,This detection technology provides a fast and efficient transformation path, while supporting sustainable development goals and operations.